114 related articles for article (PubMed ID: 29634128)
1. [Changes in the concentration of urolitiasis markers depending on stone-forming activity in patients with recurrent urolithiasis].
Kamalov AA; Okhobotov DA; Nizov AN
Urologiia; 2018 Mar; (1):15-19. PubMed ID: 29634128
[TBL] [Abstract][Full Text] [Related]
2. [Antioxidative activity and clinical efficiency of dietary supplements Nefradoz for treatment of recurrent calcium oxalate urolithiasis].
Kamalov AA; Okhobotov DA; Proskurnina EV; Sozarukova MM; Nizov AN
Urologiia; 2018 Dec; (6):52-59. PubMed ID: 30742378
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Cross-correlations Between Selected Macromolecules in Urine of Children with Idiopathic Hypercalciuria.
Jobs K; Jung A; Lewicki S; Murawski P; Pączek L; Zdanowski R
Urol J; 2018 Sep; 15(5):231-237. PubMed ID: 29353465
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, pathophysiological mechanisms and factors affecting urolithiasis.
Khan A
Int Urol Nephrol; 2018 May; 50(5):799-806. PubMed ID: 29569213
[TBL] [Abstract][Full Text] [Related]
5. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
[TBL] [Abstract][Full Text] [Related]
6. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
[TBL] [Abstract][Full Text] [Related]
7. [Determination of calcium metabolism markers concentration in patients with calcium oxalate nephrolithiasis].
Porhanov VA; Medvedev VL; Budanov AA; Kurzanov AN; Basov AA
Urologiia; 2021 Mar; (1):60-65. PubMed ID: 33818937
[TBL] [Abstract][Full Text] [Related]
8. Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney.
Atmani F; Glenton PA; Khan SR
Urol Res; 1999; 27(1):63-7. PubMed ID: 10092155
[TBL] [Abstract][Full Text] [Related]
9. Effects of a urolith prevention diet on urine compositions of glycosaminoglycans, Tamm-Horsfall glycoprotein, and nephrocalcin in cats with calcium oxalate urolithiasis.
Lulich JP; Osborne CA; Carvalho M; Nakagawa Y
Am J Vet Res; 2012 Mar; 73(3):447-51. PubMed ID: 22369540
[TBL] [Abstract][Full Text] [Related]
10. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
11. High calcium concentration and calcium oxalate crystals cause significant inaccuracies in the measurement of urinary osteopontin by enzyme linked immunosorbent assay.
Thurgood LA; Grover PK; Ryall RL
Urol Res; 2008 May; 36(2):103-10. PubMed ID: 18478219
[TBL] [Abstract][Full Text] [Related]
12. The risk of recurrent urolithiasis in children is dependent on urinary calcium and citrate.
DeFoor WR; Jackson E; Minevich E; Caillat A; Reddy P; Sheldon C; Asplin J
Urology; 2010 Jul; 76(1):242-5. PubMed ID: 20110113
[TBL] [Abstract][Full Text] [Related]
13. Quantification of osteopontin in the urine of healthy and stone-forming men.
Yasui T; Fujita K; Hayashi Y; Ueda K; Kon S; Maeda M; Uede T; Kohri K
Urol Res; 1999 Aug; 27(4):225-30. PubMed ID: 10460890
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.
Anan G; Yoneyama T; Noro D; Tobisawa Y; Hatakeyama S; Sutoh Yoneyama M; Yamamoto H; Imai A; Iwamura H; Kohada Y; Mikami J; Ito J; Kaiho Y; Yoneyama T; Hashimoto Y; Sato M; Ohyama C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877766
[TBL] [Abstract][Full Text] [Related]
15. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
16. Excretion of bikunin and its fragments in the urine of patients with renal stones.
Suzuki M; Kobayashi H; Kageyama S; Shibata K; Fujie M; Terao T
J Urol; 2001 Jul; 166(1):268-74. PubMed ID: 11435884
[TBL] [Abstract][Full Text] [Related]
17. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients.
Evan AP; Bledsoe S; Worcester EM; Coe FL; Lingeman JE; Bergsland KJ
Kidney Int; 2007 Dec; 72(12):1503-11. PubMed ID: 17898697
[TBL] [Abstract][Full Text] [Related]
18. Metabolic disturbances in Chinese children with urolithiasis: a single center report.
Yang D; Tiselius HG; Lan C; Chen D; Chen K; Ou L; Liu Y; Xu S; Zeng G; Lei M; Wu W
Urolithiasis; 2017 Jun; 45(3):285-290. PubMed ID: 27510800
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
Marengo SR; Resnick MI; Yang L; Chung JY
J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
[TBL] [Abstract][Full Text] [Related]
20. Urinary concentration of osteopontin and association with urinary supersaturation and crystal formation.
Tsuji H; Tohru U; Hirotsugu U; Masanori I; Yuji H; Takashi K
Int J Urol; 2007 Jul; 14(7):630-4. PubMed ID: 17645608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
